ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.840
-0.440 (-8.33%)
At close: Aug 1, 2025, 4:00 PM
4.610
-0.230 (-4.75%)
After-hours: Aug 1, 2025, 7:51 PM EDT

ENDRA Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Selling, General & Admin
6.837.635.526.66.025.58
Upgrade
Research & Development
2.683.1956.555.485.92
Upgrade
Operating Expenses
9.5110.8210.5213.1611.511.5
Upgrade
Operating Income
-9.51-10.82-10.52-13.16-11.5-11.5
Upgrade
Interest Expense
------0.23
Upgrade
Other Non Operating Income (Expenses)
-0.29-0.690.46-0.02-0.040.01
Upgrade
EBT Excluding Unusual Items
-9.77-11.51-10.06-13.18-11.54-11.73
Upgrade
Other Unusual Items
----0.31-
Upgrade
Pretax Income
-9.77-11.51-10.06-13.18-11.23-11.73
Upgrade
Net Income
-9.77-11.51-10.06-13.18-11.23-11.73
Upgrade
Preferred Dividends & Other Adjustments
----0.120.4
Upgrade
Net Income to Common
-9.77-11.51-10.06-13.18-11.35-12.12
Upgrade
Shares Outstanding (Basic)
00----
Upgrade
Shares Outstanding (Diluted)
00----
Upgrade
EPS (Basic)
-28.73-56.94----
Upgrade
EPS (Diluted)
-28.73-56.94----
Upgrade
Free Cash Flow
-6.56-7.42-9.58-12.97-11.17-10.82
Upgrade
Free Cash Flow Per Share
-19.28-36.70----
Upgrade
EBITDA
-9.46-10.77-10.4-13.06-11.38-11.4
Upgrade
D&A For EBITDA
0.040.050.120.10.120.1
Upgrade
EBIT
-9.51-10.82-10.52-13.16-11.5-11.5
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q